Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: Efficacy and adverse reactions during initial treatment and long-term outcome

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 5-6, 2011, Pages 257-263

  Sato, Hirokazu ^a   Minagawa, Masanori ^b   Sasaki, Nozomu ^c   Sugihara, Shigetaka ^d   Kazukawa, Itsuro ^e   Minamitani, Kanshi ^f   Wataki, Kunio ^g   Konda, Susumu ^h   Inomata, Hiroaki ⁱ   Sanayama, Kazunori ^j   Kohno, Yoichi ^b  

^a Sunrise Children's Clinic   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e CHIBA CHILDREN'S HOSPITAL   (Japan)

^f TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^g Matsudo Municipal Hospital   (Japan)

^h Konda Children's Clinic   (Japan)

ⁱ Inomata Children's Clinic   (Japan)

^j NARITA RED CROSS HOSPITAL   (Japan)

more..

Author keywords

adolescence; anti thyroid drugs; children; Graves' disease; methimazole; propylthiouracil

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE; THYROXINE;

ADVERSE OUTCOME; ARTHRITIS; ARTICLE; CHILD; DRUG EFFICACY; FEMALE; FEVER; GRAVES DISEASE; HUMAN; LIVER DYSFUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PRURITUS; RASH; RETROSPECTIVE STUDY; SCHOOL CHILD; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ANTITHYROID AGENTS; CHILD; DRUG ERUPTIONS; FEMALE; GRAVES DISEASE; HUMANS; LIVER; MALE; METHIMAZOLE; PROPYLTHIOURACIL; RETROSPECTIVE STUDIES; THYROXINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959386478     PISSN: 0334018X     EISSN: 0334018X     Source Type: Journal    
DOI: 10.1515/JPEM.2011.194     Document Type: Article

References (27)

1. LaFranchi S. Hyperthyroidism. In: Kliegman RM, Behman RE, Jenson HB, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders and Elsevier, 2007;2332-7.
2. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905-17. (Pubitemid 40300299)
3. Okamura K, Ikenoue H, Shiroozu A, Sato K, Yoshinari M, et al. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves'hyperthyroidism. J Clin Endocrinol Metab 1987;65:719-23. (Pubitemid 17157391)
4. Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS. Adverse effects related to thionamide drugs and their dose regimen. Am J Med Sci 1989;297:216-9. (Pubitemid 19104028)
5. Nicholas WC, Fischer RG, Stevenson RA, Bass JD. Single daily dose of methimazole compared to every 8 hours propylthioura-cil in the treatment of hyperthyroidism. South Med J 1995;88: 973-6.
6. Kallner G, Vitols S, Ljunggren JG. Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves'disease. J Intern Med 1996;239:525-9. (Pubitemid 26186214)
7. Williams KV, Nayak S, Becker D, Reyes J, Burmeister LA. Fifty years of experience with propylthiouracil-associated hepa-totoxicity: what have we learned? J Clin Endocrinol Metab 1997;82:1727-33. (Pubitemid 127495175)
8. Nakamura H, Yoshimura J, Itoh K, Fukata S, Miyauchi A, et al. and Working Group of the Japan Thyroid Association for Guidelines for the Treatment of Graves'Disease. Comparison of methimazole and propylthiouracil in patients with hyperthyroid-ism caused by Graves'disease. J Clin Endocrinol Metab 2007;92: 2157-62.
9. Shiroozu A, Okamura K, Ikenoue H, Sato K, Nakashima T, et al. Treatment of hyperthyroidism with a small single daily dose of methimazole. J Clin Endocrinol Metab 1986;63:125-8. (Pubitemid 16093019)
10. Mashio Y, Beniko M, Ikota A, Mizumoto H, Kunita H. Treatment of hyperthyroidism with a small single daily dose of methima-zole. Acta Endocrinol (Copenh) 1988;119:139-44. (Pubitemid 18262659)
11. Benker G, Vitti P, Kahaly G, Raue F, Tegler L, et al. Response to methimazole in Graves'disease. The European Multicenter Study Group. Clin Endocrinol (Oxf) 1995;43:257-63.
12. Page SR, Sheard CE, Herbert M, Hopton M, Jeffcoate WJ. A comparison of 20 or 40 mg per day of carbimazole in the initial treatment of hyperthyroidism. Clin Endocrinol (Oxf) 1996;45:511-6.
13. Mashio Y, Beniko M, Matsuda A, Koizumi S, Matsuya K, et al. Treatment of hyperthyroidism with a small single daily dose of methimazole: a prospective long-term follow-up study. Endocr J 1997;44:553-8. (Pubitemid 27406764)
14. Nakamura H. Antithyroid drugs. In: Japan Thyroid Association, editor. Guidelines for the treatment of Graves'disease with anti-thyroid drug in Japan 2006. Tokyo: Nankoudou, 2006;47-55 (in Japanese).
15. Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, et al. Differences and similarities in the diagnosis and treatment of Graves'disease in Europe, Japan, and the United States. Thyroid 1991;1:129-35.
16. Sato H, Harada S, Yokoya S, Tanaka T, Asayama K, et al. Treatment for childhood-onset Graves'disease in Japan: results of nationwide questionnaire survey of pediatric endocrinologists and thyroidologists. Thyroid 2007;17:67-72. (Pubitemid 46214728)
17. Sato H, Sasaki N, Harada S, Tanaka T, Akasu F, et al. Guidelines for the treatment of childhood-onset Graves'disease with anti-thyroid drug in Japan 2008. J Jap Pediatr Soc 2008;112:946-52 (in Japanese).
18. Rivkees SA, Mattison DR. Ending propylthiouracil-induced liver failure in children. N Engl J Med 2009;350:1574-5.
19. Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab 2009;94:1881-2.
20. Nakajima H, Niimi H, Matsumoto S, Horiguchi T, Fujimori M, et al. Treatment of hyperthyroidism in children. Shounika 1970;11:1133-9 (in Japanese).
21. Tsuyusaki T. Prognosis of children with Graves'disease treated with antithyroid drug. Chibaigaku 1989;65:227-34 (in Japanese). (Pubitemid 19233878)
22. Gunton JE, Stiel J, Caterson RJ, McElduff A. Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 1999;84:13-6. (Pubitemid 29036673)
23. Sato H, Hattori M, Fujieda M, Sugihara S, Inomata H, et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves'disease treated with propylthiouracil. J Clin Endocrinol Metab 2000;85:4270-3. (Pubitemid 32055385)
24. The Japan Thyroid Association. Guideline for the diagnosis of Graves' disease. http://www.japanthyroid.jp/doctor/guideline/english.html
25. Sasaki N, Nakamura Y, Niimi H, Nakajima H. Antithyroid drug therapy to hyperthyroidism. Assessment of T3 suppression test to assess the withdrawal of treatment. Shounika 1987;31:1655-60 (in Japanese).
26. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, et al. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 2000;85:3678-82.
27. Gruneiro-Papendieck L, Chiesa A, Finkielstain G, Heinrich JJ. Pediatric Graves'disease: outcome and treatment. J Pediatr Endocrinol Metab 2003;16:1249-55.